Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Jun 14, 2012 · 10-Q · 45 days after period end · 0001387131-12-001886
| Metric | Q2 2012 | Q2 2011 |
|---|---|---|
| Net Income | -$2.15K | -$1.20K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Apr 30, 2012 · filed Jun 14, 2012 · 45 d after period end
